Hodgkin Lymphoma

Hematology/Oncology Clinics of North America

Volumn 23, Issue 4, 2009, Pages 747-768

  Schnitzer, Bertram ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Classification; History; Hodgkin lymphoma; Immunophenotype; Molecular genetics; Pathology

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; RITUXIMAB; TRANSCRIPTION FACTOR PAX5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CLASSIFICATION; CANCER MORPHOLOGY; CANCER RELAPSE; CANCER STAGING; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; LYMPHOCYTE-RICH CLASSICAL HODGKIN LYMPHOMA; MALIGNANT TRANSFORMATION; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW;

HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; INCIDENCE; LYMPHOCYTES; PROGNOSIS; REED-STERNBERG CELLS; UNITED STATES;

EID: 67649436007     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.04.013     Document Type: Review

References (142)

1. Hodgkin T. On some morbid experiences of the absorbent glands and spleen. Med Clir Trans 17 (1832) 69-97
2. Wilks S. Cases of enlargement of the lymphatic glands and spleen (or Hodgkin's disease), with remarks. Guys Hosp Rep 11 (1865) 56-67
3. Sternberg C. Ueber eine Eigenartige unter dem Bilde der Pseudoleukaemie verlaufende Tuberculosis des lymphatischen Apparates. Ztschr Heilk 19 (1898) 21-30
4. Reed D.M. On the pathological changes in Hodgkin's disease with especial reference to its relation to tuberculosis. Johns Hopkins Hosp Rep 10 (1902) 133-136
5. Langhans T. Das maligne Lymphosarkum Pseudoleukamie. Virchows Pathol Anat 54 (1872) 509-536 [in German]
6. Greenfield W.S. Specimens illustrative of the pathology of lymphadenoma and leucothemia. Trans Pathol Soc London 29 (1878) 272-304
7. Seif G.S., and Spriggs A.I. Chromosome changes in Hodgkin's disease. J Natl Cancer Inst 39 3 (1967) 557-570
8. Boecker W.R., Hossfeld D.K., Gallmeier W.M., et al. Clonal growth of Hodgkin cells. Nature 258 5532 (1975) 235-236
9. Wolf J., and Diehl V. Is Hodgkin's disease an infectious disease?. Ann Oncol 5 Suppl 1 (1994) 105-111
10. National Cancer Institute. Surveillance, Epidemiology and, End Results Program. Stat Fact Sheet. Cancer Statistics. Available at: (2005). http://www.seers.cancer.gov/statfacts/html/lymph.html Accessed January 29, 2009
11. Stein H. Introduction. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 322
12. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 26 6 (1966) 1189-1201
13. Nogova L., Reineke T., Brillant C., et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 26 3 (2008) 434-439
14. Tindle B.H., Parker J.W., and Lukes R.J. "Reed-Sternberg cells" in infectious mononucleosis?. Am J Clin Pathol 58 6 (1972) 607-617
15. Gobbi P.G., Cavalli C., Gendarini A., et al. Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer 56 12 (1985) 2874-2880
16. Atkinson K., Austin D.E., McElwain T.J., et al. Alcohol pain in Hodgkin's disease. Cancer 37 2 (1976) 895-899
17. Pel P.K. Pseudoleukaemie oder chronisches Ruckfallfieber? Berlin Klin Wochenschr 24 (1887) 644-646 [in German]
18. Ebstein W. Das chronische Ruckfallfieber, eine neue Infectionskrankheit. Berlin Klin Wochenschr 24 (1887) 565-568 [in German]
19. Lister T.A., Crowther D., Sutcliffe S.B., et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7 11 (1989) 1630-1636
20. Rosenberg S.A., and Kaplan H.S. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res 26 6 (1966) 1225-1231
21. Errante D., Zagonel V., Vaccher E., et al. Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival. Ann Oncol 5 Suppl 2 (1994) 37-40
22. Wolkov H., Constine L., Yahalom J., et al. Staging evaluation - Hodgkin's disease (2005), American College of Radiology (ACR), Reston (VA) p. 15
23. Diehl V., Sextro M., Franklin J., et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 17 3 (1999) 776-783
24. Shimabukuro-Vornhagen A., Haverkamp H., Engert A., et al. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. J Clin Oncol 23 24 (2005) 5739-5745
25. Nogova L., Reineke T., Eich H.T., et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 16 10 (2005) 1683-1687
26. Connors J.M. State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol 23 26 (2005) 6400-6408
27. Josting A., Wolf J., and Diehl V. Hodgkin disease: prognostic factors and treatment strategies. Curr Opin Oncol 12 5 (2000) 403-411
28. Diehl V., Franklin J., Sextro M., et al. Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease. In: Mauch P., Armitage J.O., and Diehl V. (Eds). Hodgkin's disease (1999), Lippincott Williams & Wilkins, Philadelphia 563-582
29. Murphy S.B., Morgan E.R., Katzenstein H.M., et al. Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents. J Pediatr Hematol Oncol 25 9 (2003) 684-687
30. Mason D.Y., Banks P.M., Chan J., et al. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Surg Pathol 18 5 (1994) 526-530
31. Pellegrino B., Terrier-Lacombe M.J., Oberlin O., et al. Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection - a study of the French Society of Pediatric Oncology. J Clin Oncol 21 15 (2003) 2948-2952
32. Dores G.M., Metayer C., Curtis R.E., et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20 16 (2002) 3484-3494
33. Ekstrand B.C., Lucas J.B., Horwitz S.M., et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood 101 11 (2003) 4285-4289
34. Azim Jr. H.A., Pruneri G., Cocorocchio E., et al. Rituximab in lymphocyte-predominant Hodgkin disease. Oncology 76 1 (2008) 26-29
35. Pappa V.I., Norton A.J., Gupta R.K., et al. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases. Ann Oncol 6 6 (1995) 559-565
36. Jackson H., and Parker F. Hodgkin's disease and allied disorders (1947), Oxford University Press, New York
37. Lukes R., Butler J., and Hicks E. Natural history of Hodgkin's disease as related to its pathological picture. Cancer 19 (1966) 317-344
38. Smetana H.F., and Cohen B.M. Mortality in relation to histologic type in Hodgkin's disease. Blood 11 3 (1956) 211-224
39. Lukes R., Craver L., Hall T., et al. Report of the nomenclature committee. Cancer Res 26 (1966) 1311
40. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 5 (1994) 1361-1392
41. Anagnostopoulos I., Hansmann M.L., Franssila K., et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96 5 (2000) 1889-1899
42. Jaffe E., Harris N., Stein H., et al. World Health Organization classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France
43. Poppema S., Delsol G., Pileri S., et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 323-325
44. Weiss L.M., Von Wasielewski R., Delsol G., et al. Mixed cellularity classical Hodgkin lymphoma. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 331
45. Neiman R.S. Current problems in the histopathologic diagnosis and classification of Hodgkin's disease. Pathol Annu 13 Pt 2 (1978) 289-328
46. Delsol G., Meggetto F., Brousset P., et al. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am J Pathol 142 6 (1993) 1729-1738
47. Kadin M.E. Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep 66 4 (1982) 601-608
48. Kadin M.E., Stites D.P., Levy R., et al. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med 299 22 (1978) 1208-1214
49. Soderstrom K.O., Rinne R., Hopsu-Havu V.K., et al. Hodgkin's disease: a malignancy of follicular dendritic cells?. Lancet 343 8894 (1994) 422-423
50. Stein H., and Hummel M. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies. Semin Hematol 36 3 (1999) 233-241
51. Schwering I., Brauninger A., Klein U., et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101 4 (2003) 1505-1512
52. Stein H., Del sol G., Pileri S., et al. Classical Hodgkin lymphoma introduction WHO. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 326-329
53. Muschen M., Rajewsky K., Brauninger A., et al. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med 191 2 (2000) 387-394
54. Seitz V., Hummel M., Marafioti T., et al. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95 10 (2000) 3020-3024
55. Sheibani K., Battifora H., Burke J.S., et al. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Surg Pathol 10 4 (1986) 227-236
56. Stein H., Hansmann M.L., Lennert K., et al. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 86 3 (1986) 292-297
57. Stein H., Marafioti T., Foss H.D., et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97 2 (2001) 496-501
58. Hsu S.M., and Jaffe E.S. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. Am J Clin Pathol 82 1 (1984) 29-32
59. Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 4 (1985) 848-858
60. Stein H., Uchanska-Ziegler B., Gerdes J., et al. Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 29 3 (1982) 283-290
61. Pinkus G.S., Pinkus J.L., Langhoff E., et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am J Pathol 150 2 (1997) 543-562
62. Schwarting R., Gerdes J., Durkop H., et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74 5 (1989) 1678-1689
63. Fan G., Kotylo P., Neiman R.S., et al. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol 119 2 (2003) 199-204
64. Bakshi N.A., Finn W.G., Schnitzer B., et al. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Arch Pathol Lab Med 131 5 (2007) 742-747
65. von Wasielewski R., Mengel M., Fischer R., et al. Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol 151 4 (1997) 1123-1130
66. Portlock C.S., Donnelly G.B., Qin J., et al. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol 125 6 (2004) 701-708
67. Rassidakis G.Z., Medeiros L.J., Viviani S., et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol 20 5 (2002) 1278-1287
68. Tzankov A., Krugmann J., Fend F., et al. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases. Clin Cancer Res 9 4 (2003) 1381-1386
69. Dorfman D.M., Brown J.A., Shahsafaei A., et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 30 7 (2006) 802-810
70. Nam-Cha S.H., Roncador G., Sanchez-Verde L., et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32 8 (2008) 1252-1257
71. Khalidi H.S., Lones M.A., Zhou Y., et al. Detection of Epstein-Barr virus in the L & H cells of nodular lymphocyte predominance Hodgkin's disease: report of a case documented by immunohistochemical, in situ hybridization, and polymerase chain reaction methods. Am J Clin Pathol 108 6 (1997) 687-692
72. Braeuninger A., Kuppers R., Strickler J.G., et al. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A 94 17 (1997) 9337-9342
73. Marafioti T., Hummel M., Anagnostopoulos I., et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 337 7 (1997) 453-458
74. Ohno T., Stribley J.A., Wu G., et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med 337 7 (1997) 459-465
75. Kanzler H., Kuppers R., Hansmann M.L., et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184 4 (1996) 1495-1505
76. Brauninger A., Hansmann M.L., Strickler J.G., et al. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med 340 16 (1999) 1239-1247
77. Marafioti T., Hummel M., Anagnostopoulos I., et al. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol 17 12 (1999) 3804-3809
78. Boudova L., Torlakovic E., Delabie J., et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102 10 (2003) 3753-3758
79. Orlandi E., Lazzarino M., Brusamolino E., et al. Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma 26 3-4 (1997) 359-368
80. Nguyen P.L., Ferry J.A., and Harris N.L. Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study. Am J Surg Pathol 23 1 (1999) 27-33
81. Hansmann M.L., Wacker H.H., and Radzun H.J. Paragranuloma is a variant of Hodgkin's disease with predominance of B-cells. Virchows Arch A Pathol Anat Histopathol 409 2 (1986) 171-181
82. Hansmann M.L., and Kuppers R. Pathology and "molecular histology" of Hodgkin's disease and the border to non-Hodgkin's lymphomas. Baillieres Clin Haematol 9 3 (1996) 459-477
83. Fan Z., Natkunam Y., Bair E., et al. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27 10 (2003) 1346-1356
84. Kamel O.W., Gelb A.B., Shibuya R.B., et al. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 142 2 (1993) 541-546
85. Khoury J.D., Jones D., Yared M.A., et al. Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 28 4 (2004) 489-495
86. Huang J.Z., Weisenburger D.D., Vose J.M., et al. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 45 8 (2004) 1551-1557
87. Fanale M.A., and Younes A. Nodular lymphocyte predominant Hodgkin's lymphoma. Cancer Treat Res 142 (2008) 367-381
88. Grossman D.M., Hanson C.A., and Schnitzer B. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma. Am J Surg Pathol 15 7 (1991) 668-676
89. Greiner T.C., Gascoyne R.D., Anderson M.E., et al. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 88 2 (1996) 657-666
90. Wickert R.S., Weisenburger D.D., Tierens A., et al. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 86 6 (1995) 2312-2320
91. Hell K., Hansmann M.L., Pringle J.H., et al. Combination of Hodgkin's disease and diffuse large cell lymphoma: an in situ hybridization study for immunoglobulin light chain messenger RNA. Histopathology 27 6 (1995) 491-499
92. Hansmann M.L., Stein H., Fellbaum C., et al. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 20 12 (1989) 1169-1175
93. Chittal S.M., Alard C., Rossi J.F., et al. Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol 14 11 (1990) 1024-1035
94. Specht L., and Hasenclever D. Prognostic factors of Hodgkin's disease. In: Mauch P., Armitage J.O., and Diehl V. (Eds). Hodgkin's disease (1999), Lippincott Williams & Wilkins, Philadelphia 295-325
95. Colby T.V., Hoppe R.T., and Warnke R.A. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer 49 9 (1982) 1848-1858
96. Pileri S.A., Ascani S., Leoncini L., et al. Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol 55 3 (2002) 162-176
97. Strickler J.G., Michie S.A., Warnke R.A., et al. The "syncytial variant" of nodular sclerosing Hodgkin's disease. Am J Surg Pathol 10 7 (1986) 470-477
98. Moran C.A., Suster S., Przygodzki R.M., et al. Primary germ cell tumors of the mediastinum: II. Mediastinal seminomas - a clinicopathologic and immunohistochemical study of 120 cases. Cancer 80 4 (1997) 691-698
99. Mangini J., Li N., and Bhawan J. Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am J Dermatopathol 24 3 (2002) 270-281
100. Herbst H., Dallenbach F., Hummel M., et al. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A 88 11 (1991) 4766-4770
101. Weiss L.M. Epstein-Barr virus and Hodgkin's disease. Curr Oncol Rep 2 2 (2000) 199-204
102. Weiss L.M., Movahed L.A., Warnke R.A., et al. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320 8 (1989) 502-506
103. van Spronsen D.J., Vrints L.W., Hofstra G., et al. Disappearance of prognostic significance of histiopathologic grading of nodular sclerosing Hodgkin's disease for unselected patients, 1927-92. Br J Haematol 96 (1997) 322-327
104. Stein H., Von Wasielewski R., Poppema S., et al. Nodular sclerosis classical Hodgkin lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 330
105. Hess J.L., Bodis S., Pinkus G., et al. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients. Cancer 74 2 (1994) 708-714
106. Delsol G., Al Saati T., Gatter K.C., et al. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130 1 (1988) 59-70
107. Del sol G., Falini B., and Muller-Hermelink H.K. Anaplastic large cell lymphoma (ALCL) ALK-positive. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 312-319
108. Cazals-Hatem D., Lepage E., Brice P., et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20 7 (1996) 877-888
109. Lazzarino M., Orlandi E., Paulli M., et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 15 4 (1997) 1646-1653
110. Savage K.J., Al-Rajhi N., Voss N., et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 17 1 (2006) 123-130
111. Zinzani P.L., Martelli M., Bertini M., et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 87 12 (2002) 1258-1264
112. Carithers H.A. Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child 139 11 (1985) 1124-1133
113. Traverse-Glehen A., Pittaluga S., Gaulard P., et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29 11 (2005) 1411-1421
114. Calvo K.R., Traverse-Glehen A., Pittaluga S., et al. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 11 5 (2004) 227-238
115. Jaffe E., Stein H., Swerdlow S., et al. B-Cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In: Swerdlow S., Campo E., and Harris N. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues (2008), IARC Press, Lyon, France 267-268
116. Bacchi C.E., Dorfman R.F., Hoppe R.T., et al. Metastatic carcinoma in lymph nodes simulating "syncytial variant" of nodular sclerosing Hodgkin's disease. Am J Clin Pathol 96 5 (1991) 589-593
117. Zarate-Osorno A., Jaffe E.S., and Medeiros L.J. Metastatic nasopharyngeal carcinoma initially presenting as cervical lymphadenopathy. A report of two cases that resembled Hodgkin's disease. Arch Pathol Lab Med 116 8 (1992) 862-865
118. Ashton-Key M., Thorpe P.A., Allen J.P., et al. Follicular Hodgkin's disease. Am J Surg Pathol 19 11 (1995) 1294-1299
119. Kansal R., Singleton T.P., Ross C.W., et al. Follicular Hodgkin lymphoma: a histopathologic study. Am J Clin Pathol 117 1 (2002) 29-35
120. Quinones-Avila Mdel P., Gonzalez-Longoria A.A., Admirand J.H., et al. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases. Am J Clin Pathol 123 5 (2005) 651-656
121. Biggar R.J., Jaffe E.S., Goedert J.J., et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108 12 (2006) 3786-3791
122. Patsouris E., Noel H., and Lennert K. Cytohistologic and immunohistochemical findings in Hodgkin's disease, mixed cellularity type, with a high content of epithelioid cells. Am J Surg Pathol 13 12 (1989) 1014-1022
123. Pileri S., Weisenburger D.D., Sng I., et al. Peripheral T-cell lymphoma, not otherwise specified. In: Swerdlow S., Campo E., Harris N., et al. (Eds). WHO classifications of tumours of haematopoietic and lymphoid tissues. 4th edition (2008), IARC Press, Lyon, France 306-308
124. Barry T.S., Jaffe E.S., Sorbara L., et al. Peripheral T-cell lymphomas expressing CD30 and CD15. Am J Surg Pathol 27 12 (2003) 1513-1522
125. Banks P.M. The distinction of Hodgkin's disease from T cell lymphoma. Semin Diagn Pathol 9 4 (1992) 279-283
126. Hastrup N., Ralfkiaer E., and Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 42 4 (1989) 398-402
127. Vassallo J., Paes R.P., Soares F.A., et al. Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of Sao Paulo, Brazil. Sao Paulo Med J 123 3 (2005) 134-136
128. Allemani C., Sant M., De Angelis R., et al. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 107 2 (2006) 352-360
129. Neiman R.S., Rosen P.J., and Lukes R.J. Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity. N Engl J Med 288 15 (1973) 751-755
130. Glaser S.L., Clarke C.A., Gulley M.L., et al. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 98 2 (2003) 300-309
131. Lukes R.J., and Butler J.J. The pathology and nomenclature of Hodgkin's disease. Cancer Res 26 6 (1966) 1063-1083
132. Lukes R.J. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res 31 11 (1971) 1755-1767
133. Herndier B.G., Sanchez H.C., Chang K.L., et al. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease. Am J Pathol 142 4 (1993) 1073-1079
134. Uccini S., Monardo F., Stoppacciaro A., et al. High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 46 4 (1990) 581-585
135. Doggett R.S., Colby T.V., and Dorfman R.F. Interfollicular Hodgkin's disease. Am J Surg Pathol 7 2 (1983) 145-149
136. Fellbaum C., Hansmann M.L., and Lennert K. Lymphadenitis mimicking Hodgkin's disease. Histopathology 12 3 (1988) 253-262
137. Yates P., Stockdill G., and McIntyre M. Hypersensitivity to carbamazepine presenting as pseudolymphoma. J Clin Pathol 39 11 (1986) 1224-1228
138. Schnitzer B. Reactive lymphadenopathies. In: Knowles D.M. (Ed). Neoplastic hematopathology (2001), Lippincott Williams and Williams, Philadelphia 537-568
139. Weiss S.W., and Enzinger F.M. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41 6 (1978) 2250-2266
140. Biggar R.J., Chaturvedi A.K., Goedert J.J., et al. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99 12 (2007) 962-972
141. Clifford G.M., Polesel J., Rickenbach M., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 6 (2005) 425-432
142. Grogg K.L., Miller R.F., and Dogan A. HIV infection and lymphoma. J Clin Pathol 60 12 (2007) 1365-1372